Idorsia Ltd (IDRSF)
USD 1.0
(0.0%)
USD 1.0
(0.0%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 931 Million CHF | -23.59% |
| 2022 | 1.21 Billion CHF | 5.66% |
| 2021 | 1.15 Billion CHF | 82.91% |
| 2020 | 630.46 Million CHF | 1.27% |
| 2019 | 622.58 Million CHF | 9.06% |
| 2018 | 570.84 Million CHF | 56.53% |
| 2017 | 364.68 Million CHF | 24.29% |
| 2016 | 293.42 Million CHF | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | 931.39 Million CHF | 0.02% |
| 2024 Q1 | 931.19 Million CHF | 0.02% |
| 2023 Q4 | 931 Million CHF | -6.84% |
| 2023 Q2 | 1.2 Billion CHF | -1.24% |
| 2023 FY | 931 Million CHF | -23.59% |
| 2023 Q1 | 1.21 Billion CHF | -0.2% |
| 2023 Q3 | 999.3 Million CHF | -16.79% |
| 2022 Q2 | 1.19 Billion CHF | 0.34% |
| 2022 Q4 | 1.21 Billion CHF | 2.53% |
| 2022 FY | 1.21 Billion CHF | 5.66% |
| 2022 Q1 | 1.18 Billion CHF | 3.0% |
| 2022 Q3 | 1.18 Billion CHF | -0.29% |
| 2021 Q1 | 630.22 Million CHF | -0.04% |
| 2021 FY | 1.15 Billion CHF | 82.91% |
| 2021 Q4 | 1.15 Billion CHF | -7.34% |
| 2021 Q3 | 1.24 Billion CHF | 97.53% |
| 2021 Q2 | 630.02 Million CHF | -0.03% |
| 2020 Q4 | 630.46 Million CHF | 0.55% |
| 2020 FY | 630.46 Million CHF | 1.27% |
| 2020 Q1 | 625.58 Million CHF | 0.48% |
| 2020 Q3 | 627.03 Million CHF | 0.15% |
| 2020 Q2 | 626.11 Million CHF | 0.08% |
| 2019 Q2 | 630.37 Million CHF | 1.03% |
| 2019 Q4 | 622.58 Million CHF | -1.42% |
| 2019 FY | 622.58 Million CHF | 9.06% |
| 2019 Q3 | 631.53 Million CHF | 0.18% |
| 2019 Q1 | 623.92 Million CHF | 9.3% |
| 2018 Q3 | 568.81 Million CHF | 54.36% |
| 2018 FY | 570.84 Million CHF | 56.53% |
| 2018 Q2 | 368.48 Million CHF | 0.52% |
| 2018 Q1 | 366.57 Million CHF | 0.52% |
| 2018 Q4 | 570.84 Million CHF | 0.36% |
| 2017 Q1 | 296.88 Million CHF | 0.0% |
| 2017 FY | 364.68 Million CHF | 24.29% |
| 2017 Q4 | 364.68 Million CHF | 0.53% |
| 2017 Q3 | 362.76 Million CHF | 0.5% |
| 2017 Q2 | 360.95 Million CHF | 21.58% |
| 2016 FY | 293.42 Million CHF | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Bioxytran, Inc. | - USD | -Infinity% |
| Eiger BioPharmaceuticals, Inc. | - USD | -Infinity% |
| Institute of Biomedical Research Corp. | - USD | -Infinity% |
| SQZ Biotechnologies Company | 20.9 Million USD | -4352.642% |
| Intellipharmaceutics International Inc. | - USD | -Infinity% |
| Evofem Biosciences, Inc. | 8000.00 USD | -11637437.5% |
| Santhera Pharmaceuticals Holding AG | 1.75 Million USD | -52934.129% |
| Propanc Biopharma, Inc. | 58.64 Thousand USD | -1587504.447% |
| Marizyme, Inc. | 667.12 Thousand USD | -139453.67% |
| Genus plc | 228.2 Million USD | -307.977% |
| Pharming Group N.V. | 166.1 Million USD | -460.491% |
| Therapeutic Solutions International, Inc. | 5512.00 USD | -16890375.327% |
| CNBX Pharmaceuticals Inc. | - USD | -Infinity% |
| Nymox Pharmaceutical Corporation | - USD | -Infinity% |
| ContraFect Corporation | 2.21 Million USD | -42026.833% |
| RegeneRx Biopharmaceuticals, Inc. | 1.4 Million USD | -66261.14% |
| IMV Inc. | 27.39 Million USD | -3297.998% |
| AXIM Biotechnologies, Inc. | 5.42 Million USD | -17056.665% |
| ONE Bio Corp. | 592.19 Thousand USD | -157111.439% |
| RVL Pharmaceuticals plc | 55.61 Million USD | -1574.105% |
| Mesoblast Limited | 100.29 Million USD | -828.265% |
| MultiCell Technologies, Inc. | 36.43 USD | -2555594190.42% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| Emmaus Life Sciences, Inc. | 2.22 Million USD | -41724.034% |
| Genscript Biotech Corporation | 287.12 Million USD | -224.245% |
| Neon Bloom, Inc. | - USD | -Infinity% |
| Mosaic ImmunoEngineering Inc. | 1.22 Million USD | -75692.296% |
| Nanobac Pharmaceuticals, Incorporated | - USD | -Infinity% |
| Biomind Labs Inc. | - USD | -Infinity% |
| Provectus Biopharmaceuticals, Inc. | 25.29 Thousand USD | -3679899.209% |
| Oncotelic Therapeutics, Inc. | 1.89 Million USD | -48939.699% |
| Skye Bioscience, Inc. | 171.23 Thousand USD | -543614.886% |
| GlobeStar Therapeutics Corporation | - USD | -Infinity% |
| VioQuest Pharmaceuticals, Inc. | - USD | -Infinity% |
| THC Farmaceuticals, Inc. | - USD | -Infinity% |
| PsyBio Therapeutics Corp. | - USD | -Infinity% |
| Arch Therapeutics, Inc. | - USD | -Infinity% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| Acro Biomedical Co., Ltd. | - USD | -Infinity% |
| Accustem Sciences Inc. | - USD | -Infinity% |
| EV Biologics, Inc. | - USD | -Infinity% |
| Q BioMed Inc. | - USD | -Infinity% |
| GB Sciences, Inc. | 322 Thousand USD | -289031.366% |
| Alpha Cognition Inc. | - USD | -Infinity% |
| CSL Limited | 11.23 Billion USD | 91.716% |
| Agentix Corp. | - USD | -Infinity% |
| American Oriental Bioengineering, Inc. | 554.59 Thousand USD | -167772.302% |
| Enzolytics Inc. | - USD | -Infinity% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| Resverlogix Corp. | - USD | -Infinity% |
| Nuo Therapeutics, Inc. | 164.2 Thousand USD | -566876.036% |
| MetaStat, Inc. | - USD | -Infinity% |
| Curative Biotechnology, Inc. | - USD | -Infinity% |
| argenx SE | 15.35 Million USD | -5963.586% |
| Northwest Biotherapeutics, Inc. | 20.31 Million USD | -4483.512% |
| HST Global, Inc. | - USD | -Infinity% |
| Enzon Pharmaceuticals, Inc. | - USD | -Infinity% |
| Wesana Health Holdings Inc. | - USD | -Infinity% |
| Halberd Corporation | 150 Thousand USD | -620568.667% |
| Endonovo Therapeutics, Inc. | - USD | -Infinity% |
| Inhibitor Therapeutics, Inc. | - USD | -Infinity% |
| Zenith Capital Corp. | 4456.00 USD | -20893145.063% |
| RespireRx Pharmaceuticals Inc. | - USD | -Infinity% |
| GeneThera, Inc. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | 126.3 Thousand USD | -737024.511% |
| AVAX Technologies, Inc. | - USD | -Infinity% |
| WPD Pharmaceuticals Inc. | 229.29 Thousand USD | -405935.562% |
| Cotinga Pharmaceuticals Inc. | - USD | -Infinity% |
| Ember Therapeutics, Inc. | - USD | -Infinity% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| Adynxx, Inc. | - USD | -Infinity% |
| NovAccess Global Inc. | - USD | -Infinity% |
| Helix BioMedix, Inc. | - USD | -Infinity% |
| Capstone Therapeutics Corp. | 8.26 Million USD | -11165.767% |
| Kadimastem Ltd | 229.69 Thousand USD | -405228.463% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| BioStem Technologies, Inc. | 265.63 Thousand USD | -350382.052% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Reve Technologies, Inc. | 1064.00 USD | -87500181.955% |
| Burzynski Research Institute, Inc. | - USD | -Infinity% |
| LadRx Corporation | - USD | -Infinity% |
| Cell Source, Inc. | - USD | -Infinity% |
| ProtoKinetix, Incorporated | - USD | -Infinity% |
| Regen BioPharma, Inc. | 149.61 Thousand USD | -622169.975% |
| Regen BioPharma, Inc. | 149.61 Thousand USD | -622169.975% |
| Affymax, Inc. | - USD | -Infinity% |
| Mobile Lads Corp. | - USD | -Infinity% |
| Itoco Inc. | - USD | -Infinity% |
| Rasna Therapeutics, Inc. | - USD | -Infinity% |
| Pathfinder Cell Therapy, Inc. | - USD | -Infinity% |
| International Stem Cell Corporation | 445 Thousand USD | -209114.157% |
| CytoDyn Inc. | 141 Thousand USD | -660185.816% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | - USD | -Infinity% |
| NanoSphere Health Sciences Inc. | - USD | -Infinity% |
| Qrons Inc. | 80 Thousand USD | -1163653.75% |
| Alseres Pharmaceuticals, Inc. | 7.81 Million USD | -11805.47% |
| SYBLEU INC | 300 Thousand USD | -310234.333% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| Nascent Biotech, Inc. | - USD | -Infinity% |
| Rebus Holdings, Inc. | - USD | -Infinity% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| ImmunoCellular Therapeutics, Ltd. | 369.04 Thousand USD | -252170.837% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | - USD | -Infinity% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | - USD | -Infinity% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | 8.15 Million USD | -11323.35% |
| Adhera Therapeutics, Inc. | - USD | -Infinity% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | - USD | -Infinity% |
| Innovation Pharmaceuticals Inc. | 457 Thousand USD | -203620.569% |
| Neutra Corp. | - USD | -Infinity% |
| Windtree Therapeutics, Inc. | 1.16 Million USD | -80089.75% |
| PureTech Health plc | 18.25 Million USD | -5001.386% |
| Coeptis Therapeutics, Inc. | 150 Thousand USD | -620568.667% |
| IXICO plc | 275 Thousand USD | -338446.545% |
| IntelGenx Technologies Corp. | 11.83 Million USD | -7763.865% |
| Gelesis Holdings, Inc. | 26.3 Million USD | -3438.724% |
| CSL Limited | 11.23 Billion USD | 91.716% |
| Cellectis S.A. | 36.21 Million USD | -2471.04% |